The ConcertAI Podcast ConcertAI

Jeff Elton sits down with Dr. Robert Miller, Chief Medical and Science Officer at CancerLinQ, to unpack the integration of real-world data and AI in oncology care. Dr. Miller shares his journey from community practice to shaping CancerLinQ, revealing insights into the network's growth and its pivotal role in improving patient care. The episode delves into the transformation of quality measures, the burgeoning role of electronic health records, and the automation of data to enhance the quality...

Jeff Elton, CEO of ConcertAI, and George Sledge, CMO of Caris Life Sciences, embark on an insightful journey through the advancements in oncology. They explore the transformative power of molecular diagnostic testing and how comprehensive data sets are revolutionizing personalized medicine. Delving into topics like the rise of liquid biopsies, which enable non-invasive, next-gen sequencing, they highlight the potential for easier and safer tumor monitoring. Challenges like the limitations of ...

In this engaging episode, David Spetzler, President of Caris Life Sciences, and Jeff Elton, CEO of ConcertAI, discuss the transformative power of combining clinical insights and advanced AI technologies to revolutionize patient care in oncology. Highlighting their collaborative efforts, they emphasize the critical role of comprehensive data analysis, from leveraging longitudinal clinical records to employing next-generation sequencing for personalized treatment strategies. The conversation un...

The second episode of The ConcertAI Podcast features Dr. Sibel Blau and Caroline Merillat, key figures in the Quality Cancer Care Alliance (QCCA) and creators of Exigent. This initiative aims to improve clinical research in community oncology, making trials more accessible and reflective of standard care populations. Dr. Blau, motivated by a dream to cure cancer, emphasized the importance of maintaining the independence of oncology practices for superior patient care. Merillat, with extensive...

In this captivating episode of The ConcertAI Podcast, we dive deep with Jennifer Rider, a renowned cancer epidemiologist. Jennifer shares her journey from academia to the dynamic world of real-world data (RWD) and its vital role in oncology research. We explore how RWD is transforming the landscape of prostate cancer studies and its increasing importance in regulatory decision-making.Discover how the field of RWD has evolved and its pivotal contributions to the development and application of ...

We're back with The ConcertAI Podcast for Season Two! In our first episodes, we delve deep into RWE's role in regulatory applications, such as designing registrational clinical trials and developing robust data sets that shape trial designs and submissions. We're exploring the evolving landscape of efficacy, safety, and the use of external control arms, especially in light of recent FDA guidance.But that's not all. Season Two also highlights incredible progress in clinical trial networks and ...